Early data from human trials of drugmaker Moderna's experimental COVID-19 vaccine showed that it produced protective antibodies in a small group of people. Read more here: https://t.co/P7LzCUG75P pic.twitter.com/rsoUih7vZ9

— Reuters (@Reuters) May 18, 2020